Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenylephrine infusion and prophylactic oxytocin requirement during cesarean delivery
ChiCTR1800018979Phase 3Not yet recruiting
- Sponsor
- Jiaxing Maternity and Child Health Care Hospital
- Start
- Nov 2018
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of phenylephrine and oxytocin (2 arms), sponsored by Jiaxing Maternity and Child Health Care Hospital. Primary endpoints: Dose of oxytocin and Blood loss. Planned start Nov 2018; status: not yet recruiting.
02
Drugs
phenylephrineoxytocin
Beyond the preview
Go deeper on ChiCTR1800018979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800018979.